Patent intelligence · Companies
Company patent strength
Non-educational filers ranked by their patent portfolio. Grant rate and lapsed share expose where high filing volume is not matched by granted patents. Domestic filers lead — toggle to foreign applicants to see who is entering the Indian market.
Free to browse the ranking. Sign into open a filer's full profile — inventors, filing trend and quality index. See how we rank.
Why this page exists — and how to read it
Filing volume and IP quality are different things. This leaderboard ranks non-educational filers by portfolio, but the grant-rate and lapsed sorts are where the judgement lives: they separate companies whose filings survive examination from those accumulating paper.
- Investors
- High grant rate on steady filing usually means a real R&D engine; big volume with a high lapsed share is a red flag worth asking about.
- Founders & operators
- These are the incumbents and potential acquirers in your space — open a filer to see the walls you'd build against.
- Corporate & R&D
- Benchmark competitors' portfolios and grant rates; toggle to foreign to watch who is entering the Indian market.
💬 The grant-rate sort applies a 20-filing floor so tiny portfolios can't top the list.
3,207 foreign filers with 5+ patents · page 14
| # | Filer | Patents↓ | Granted↓ | Lapsed↓ | Pending↓ | Active |
|---|---|---|---|---|---|---|
| 651 | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT | 24 | 00% | 4 | 20 | 2022–2026 |
| 652 | IONIS PHARMACEUTICALS | 24 | 00% | 1 | 23 | 2022–2026 |
| 653 | JYOTI | 24 | 14.2% | 1 | 22 | 2022–2026 |
| 654 | KASHIV BIOSCIENCES | 24 | 312.5% | 2 | 19 | 2020–2025 |
| 655 | KONE | 24 | 28.3% | 0 | 22 | 2019–2026 |
| 656 | LOCUS SOLUTIONS IPCO | 24 | 00% | 7 | 17 | 2023–2026 |
| 657 | MANITOU BF | 24 | 312.5% | 0 | 21 | 2021–2025 |
| 658 | METAGENOMI | 24 | 00% | 0 | 24 | 2022–2025 |
| 659 | NIPPON SHINYAKU | 24 | 14.2% | 3 | 20 | 2022–2026 |
| 660 | NISSAN CHEMICAL | 24 | 28.3% | 0 | 22 | 2022–2026 |
| 661 | SAFRAN AIRCRAFT ENGINES | 24 | 416.7% | 0 | 20 | 2021–2026 |
| 662 | SHINDENGEN ELECTRIC MANUFACTURING | 24 | 14.2% | 0 | 23 | 2022–2026 |
| 663 | SK INNOVATION | 24 | 14.2% | 0 | 23 | 2020–2025 |
| 664 | SUPERSONIC IMAGINE | 24 | 00% | 4 | 20 | 2022–2024 |
| 665 | SWIMC | 24 | 312.5% | 1 | 20 | 2022–2026 |
| 666 | TE CONNECTIVITY INDIA | 24 | 28.3% | 0 | 22 | 2022–2025 |
| 667 | UMICORE KG | 24 | 625% | 1 | 17 | 2020–2026 |
| 668 | UPM KYMMENE | 24 | 00% | 0 | 24 | 2022–2026 |
| 669 | WHIRLPOOL | 24 | 14.2% | 0 | 23 | 2019–2025 |
| 670 | AMAZON TECHNOLOGIES | 23 | 730.4% | 0 | 16 | 2010–2026 |
| 671 | AURIGENE ONCOLOGY | 23 | 14.3% | 4 | 18 | 2022–2026 |
| 672 | BECKMAN COULTER | 23 | 626.1% | 0 | 17 | 2022–2026 |
| 673 | BREMBO | 23 | 313% | 0 | 20 | 2021–2025 |
| 674 | CHIYODA | 23 | 730.4% | 3 | 13 | 2022–2026 |
| 675 | DEEPMIND TECHNOLOGIES | 23 | 28.7% | 0 | 21 | 2022–2025 |
| 676 | ELKEM SILICONES FRANCE | 23 | 521.7% | 1 | 17 | 2022–2026 |
| 677 | ENEOS | 23 | 521.7% | 0 | 18 | 2022–2026 |
| 678 | GEA WESTFALIA SEPARATOR GROUP | 23 | 00% | 0 | 23 | 2023–2026 |
| 679 | HANGZHOU HIKVISION DIGITAL TECHNOLOGY | 23 | 730.4% | 0 | 16 | 2022–2026 |
| 680 | HUNTSMAN PETROCHEMICAL | 23 | 28.7% | 2 | 19 | 2022–2026 |
| 681 | IMMATICS BIOTECHNOLOGIES | 23 | 00% | 16 | 7 | 2022–2026 |
| 682 | INNOLUX | 23 | 1147.8% | 0 | 12 | 2020–2024 |
| 683 | JOHN COCKERILL HYDROGEN BELGIUM | 23 | 00% | 0 | 23 | 2023–2026 |
| 684 | MARELLI EUROPE | 23 | 28.7% | 1 | 20 | 2020–2025 |
| 685 | MOTOROLA MOBILITY | 23 | 14.3% | 0 | 22 | 2019–2024 |
| 686 | OURA HEALTH | 23 | 00% | 0 | 23 | 2024–2026 |
| 687 | PERI SE | 23 | 14.3% | 2 | 20 | 2021–2026 |
| 688 | PRIME POLYMER | 23 | 417.4% | 0 | 19 | 2022–2026 |
| 689 | SCHOTT PHARMA SCHWEIZ | 23 | 730.4% | 0 | 16 | 2019–2025 |
| 690 | SOLVAY SPECIALTY POLYMERS USA | 23 | 14.3% | 0 | 22 | 2022–2025 |
| 691 | TORAY ADVANCED MATERIALS KOREA | 23 | 730.4% | 0 | 16 | 2022–2025 |
| 692 | ZIEHL ABEGG SE | 23 | 14.3% | 1 | 21 | 2021–2026 |
| 693 | ABBVIE | 22 | 29.1% | 3 | 17 | 2021–2025 |
| 694 | ALADDIN MANUFACTURING | 22 | 00% | 8 | 14 | 2022–2026 |
| 695 | BAE SYSTEMS H GGLUNDS AKTIEBOLAG | 22 | 29.1% | 0 | 20 | 2022–2026 |
| 696 | CARL ZEISS MEDITEC | 22 | 313.6% | 0 | 19 | 2021–2026 |
| 697 | GLATT GESELLSCHAFT MIT BESCHR NKTER HAFTUNG | 22 | 418.2% | 0 | 18 | 2022–2026 |
| 698 | KOLON INDUSTRIES | 22 | 1045.5% | 0 | 12 | 2022–2026 |
| 699 | KURITA WATER INDUSTRIES | 22 | 14.5% | 1 | 20 | 2022–2026 |
| 700 | LIFELENS TECHNOLOGIES | 22 | 00% | 0 | 22 | 2022–2026 |
Educational institutes are excluded — see the institute leaderboard. Attribution is by patent assignee record; a jointly-owned patent is credited to each co-owner, so a co-filed patent counts for every company on it. "Lapsed" = abandoned, withdrawn, deemed-withdrawn or refused; "Pending" = awaiting examination or in prosecution. Want to filter by technology or value category? Browse the filer explorer →
Rankings use patent-registry status (grant rate, examination, claim depth) as a quality proxy — directional, not advice; see methodology. Read the ranking methodology →